More studies needed to understand true impact of microbiota on cancer development, treatment
How microbiota—microbes that live on human surfaces—impact cancer development and therapy has become an expansive area of research.
Sep 18, 2023
0
9
How microbiota—microbes that live on human surfaces—impact cancer development and therapy has become an expansive area of research.
Sep 18, 2023
0
9
Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors by measuring abnormal ...
Sep 6, 2023
0
14
Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied ...
Aug 18, 2023
1
71
A new study of mice and lab-grown human colon "organoids" indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical ...
Aug 10, 2023
0
38
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, ...
Aug 9, 2023
0
40
A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a non-invasive pain treatment, can yield significant relief for approximately 80%–90% of patients with chronic pain, and ...
Jul 31, 2023
0
148
Based on findings from a study published today in The Lancet Regional Health—Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency ...
Jul 24, 2023
0
34
Improving diagnosis in health care is a moral, professional and public health imperative, according to the U.S. National Academy of Medicine. However, little is known about the full scope of harms related to medical misdiagnosis—current ...
Jul 17, 2023
0
19
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist ...
Jul 17, 2023
0
46
In a pre-clinical, proof-of-concept study from Johns Hopkins Medicine, researchers found that epigallocatechin gallate (EGCG), a green tea compound with powerful antioxidant properties, could be promising for both treating ...
Jul 13, 2023
0
1